Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2569-2575

  Green, Kathy A ^a   Crassi, Karen M ^a   Laman, Jon D ^a   Schoneveld, Arjan ^a   Strawbridge, Rendall R ^a   Foy, Teresa M ^a   Noelle, Randolph J ^a   Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CONCANAVALIN A; GLYCOPROTEIN GP 39; LIGAND; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; HYPERGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; LYMPHADENOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RODENT DISEASE; SPLENOMEGALY;

AIDS-RELATED COMPLEX; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CRICETINAE; HYPERGAMMAGLOBULINEMIA; IMMUNITY; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; SPLEEN; SPLENOMEGALY;

EID: 0029873737     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2569-2575.1996     Document Type: Article

References (45)

1. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, J. Disteche, D. K. Simoneaux et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990-995.
2. Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Madcuff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, E. A. Clark, C. A. Smith, K. H. Grabstein, D. Cosman, and M. K. Spriggs. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (London) 357:80-82.
3. Aziz, D. C., Z. Hanna, and P. Jolicoeur. 1989. Severe immunodeficiency disease induced by a defective murine leukemia virus. Nature (London) 338:505-508.
4. Buller, R. M. L., R. A. Yetter, T. N. Fredrickson, and H. C. Morse III. 1987. Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J. Virol. 61:383-387.
5. Batcher, E. C., R. V. Rouse, R. L. Coffman, C. N. Nottenberg, R. R. Hardy, and I. Weissman. 1982. Surface phenotype of Peyer's patch germinal center cells, implications for the role of germinal centers in B cell differentiation. J. Immunol 129:2698-2703.
6. Cerny, A., A. W. Hugin, R. R. Hardy, K. Hayakawa, R. M. Zinkernagel, M. Makino, and H. C. Morse III. 1990. B cells arc required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171:315-320.
7. Chattopadhyay, S. K., H. C. Morse III, M. Makino, S. K. Ruscetti, and J. W. Hartley, 1989. A defective virus is associated with induction of a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Proc. Natl. Acad. Sci. USA 86:3862-3866.
8. Cheung, S. C., S. K. Chattopadhyay, J. W. Hartley, H. C. Morse III, and P. M. Pitha. 1991. Aberrant expression of cytokine genes in peritoneal macrophages from mice infected with LP-BM5 MuLV, a murine model of AIDS. J. Immunol. 146:121-127
9. Coico, R. F., B. S. Bhogal, and G. J. Thorbecke. 1983. Relationship of germinal centers in rymphoid tissue to immunologic memory. VI. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin. J. Immunol. 131:2254-2260.
10. Foy, T. M., A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged in vivo suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39. J. Exp. Med. 178:1567-1575
11. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. Gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med 180:157-163
12. - T cells. J. Virol. 68:5819-5824.
13. Gilmore, G. L., C. Cowing, and D. E. Mosier. 1993. LP-BM5 murine retrovirus-induced immunodeficiency disease in allogeneic SCID chimeric mice. J. Immunol. 150:185-189.
14. Green, W. R., K. A. Green, and K. M. Crassi. 1994 Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses a measure of protection against LP-BM5 retrovirus-induced immunodeficiency. J. Virol. 68:4679-4684
15. mm15. Hartley, J. W., T. N. Fredrickson, R. A. Yetter, M. Makino, and H. C. Morse III. 1989. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1223-1230.
16. gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells. J. Virol 68:5648-5655.
17. Huang, M., C. Simard, and P. Jolicoeur. 1989. Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus Science 246:1614-1617.
18. Huang, M., C. Simard, D. G. Kay, and P. Jolicoeur. 1991. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol 65:6562-6571.
19. Hugin, A. W., M. S. Vacchio, and H. C. Morse III. 1991. A virus encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science 252:424-427.
20. Hugo, P., J. W. Kappler, and P. C. Marrack. 1993. Positive selection of TcR ab thymocytes: is cortical epithelium an obligatory participant in the presentation of major histocompatibility complex protein? Immunol. Rev. 135:134-155
21. Kanagawa, O., B. A. Nussrallah, M. E. Wiebenga, K. M. Murphy, H. C. Morse III, and F. R. Carbone. 1992 Murine AIDS superantigen reactivity of the T cells bearing Vβ5 T cell antigen receptor. J. Immunol 149:9-16.
22. mm22. Klinken, S. P., T. N. Fredrickson, J. W. Hartley, R. A. Yetter, and H. C. Morse III. 1988 Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J. Immunol. 140:1123-1131.
23. mm23. Klinman, D. M., and H. C. Morse III. 1989. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1144-1149
24. Koch, S., G. Muralidhar, and S. L. Swain. 1994. Both naive and memory CD4 T cell subsets become anergic during MAIDS and each subset can sustain disease. J. Immunol. 152:5548-5556.
25. Legrand, E., R. Daculsi, and J. F. Duplan. 1981. Characteristics of the cell populations involved in extrathymic lymphosarcoma induced in C57BL/6 mice by RadLV-RS. Leuk. Res. 5:223-233.
26. mm26. Makino, M., Y. Tang, D. B. Murphy, T. N. Fredrickson, Y. Okada, M. Fajiwara, S. K. Chattopadhyay, T. Mizuochi, K. Komuro, H. C. Morse III, and J. W. Hartley. 1994. Influence of H-2 class II antigens on the development of murine AIDS. J. Immunol. 152:4157-4164.
27. Morse, H. C., III, S. K. Chattopadhyay, M. Makino, T. N. Fredrickson, H. W. Ambros, and J. W. Hartley. 1992 Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS (Philadelphia) 6:607-621
28. Morse, H. C., III, R. A. Yetter, C. S. Via, R. R. Hardy, A. Cerny, K. Hayakawa, A. W. Hugin, M. W. Miller, K. L. Homes, and G. M. Shearer. 1989 Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome J Immunol. 143:844-850.
29. Mosier, D. E., R. A. Yetter, and H. C. Morse III. 1985. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:766-784.
30. Mosier, D. E., R. A. Yetter, and H. C. Morse III. 1987. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165:1737-1742.
31. Muralidhar, G., S. Koch, M. Haas, and S. L. Swain. 1992. CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy J. Exp. Med 175:1589-1599
32. Nieuwenhuis, P., F. G. M. Kroese, D. Opstelten, and H. G. Seijen. 1992. De novo germinal center formation. Immunol. Rev. 126:77-90
33. 32a Noelle, R. J. Unpublished results.
34. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992 A novel ligand on activated T helper cells binds CD40 and transduces the signal for the cognate activation of B cells. Proc. Natl Acad. Sci. USA 89:6550-6554.
35. Pattengale, P. K., C. R. Taylor, P. Twomey, S. Hill, J. Jonasson, T. Beardsley, and M. Haas. 1982. Immunopathology of B cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am J Pathol. 107:362-377.
36. Pinchuk, L. M., P. S. Polacino, M. B. Agy, S. J. Klaus, and E. A. Clark. 1994 The role of CD40 and CD80 accessory cell molecules in dend cell-dependent HIV-1 infection. Immunity 1:317-325.
37. Ranheim, E. A., and T. J. Kipps, 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925-935.
38. Rose, M. L., M. S. C. Birbeck, V. J. Wallis, J. A. Forrester, and A. J. S. Davies. 1980. Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature (London) 284:364-382.
39. Rowe, W. P., W. E. Pugh, and J. W. Hartley. 1970. Plaque assay techniques for murine leukemia viruses. Virology 42:1136-1139.
40. Selvey, L. A., H. C. Morse III, L. G. Granger, and R. J. Hodes. 1993. Preferential expansion and activation of V beta 5+ CD4+ T cells in murine acquired immunodeficiency syndrome. J. Immunol. 151:1712-1722.
41. Svetic, A., F. D. Finkelman, Y. C. Jian, C. W. Dieffenbach, D. E. Scott, K. F. McCarthy, A. D. Steinberg, and W. C. Gause. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391-2397.
42. Uckun, F. M., G. L. Schieven, I. Dibirdik, L. M. Chandan, A. L. Tuel, and J. A. Ledbetter. 1991. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 266:17478-17485.
43. Van den Eertwegh, A. J. M., R. J. Noelle, M. Roy, D. M. Sheperd, A. Aruffo, J. A. Ledbetter, W. J. A. Boersma, and E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. 1. CD40-gp39 interactions are essential for thymus dependent humoral immunity and identify sites of cognate interactions in vivo. J. Exp. Med. 178:1555-1565.
44. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423-431.
45. + T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp. Med. 168:623-635.